104 related articles for article (PubMed ID: 33137566)
21. Correlation Analysis between Serum Vitamin D Levels and Lower Extremity Macrovascular Complications in Individuals with Type 2 Diabetes Mellitus.
Yang M; Liu J; Zhou X; Ding H; Xu J; Yang B; Sun B; Xiao D; Yu J; Gong Q
J Diabetes Res; 2019; 2019():4251829. PubMed ID: 31871946
[TBL] [Abstract][Full Text] [Related]
22. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study.
Biscetti F; Nardella E; Rando MM; Cecchini AL; Angelini F; Cina A; Iezzi R; Filipponi M; Santoliquido A; Pitocco D; Landolfi R; Flex A
Cardiovasc Diabetol; 2020 Oct; 19(1):170. PubMed ID: 33028322
[TBL] [Abstract][Full Text] [Related]
23. Association between brain imaging biomarkers and continuous glucose monitoring-derived glycemic control indices in Japanese patients with type 2 diabetes mellitus.
Inoue C; Kusunoki Y; Ohigashi M; Osugi K; Kitajima K; Takagi A; Inoue M; Yagi C; Tsunoda T; Kakutani M; Kadoya M; Konishi K; Katsuno T; Koyama H; ;
BMJ Open Diabetes Res Care; 2024 Jan; 12(1):. PubMed ID: 38233078
[TBL] [Abstract][Full Text] [Related]
24. Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients.
Wang Y; Lu J; Shen Y; Ni J; Zhang L; Lu W; Zhu W; Bao Y; Zhou J
J Diabetes Investig; 2022 Sep; 13(9):1543-1550. PubMed ID: 35435323
[TBL] [Abstract][Full Text] [Related]
25. Angiopoietin-related growth factor is independently associated with lower extremity peripheral arterial disease.
Nie H; Liang Y; Wang HX; Ren HL; Wang YW; Li FD; Zheng YH
J Diabetes Complications; 2017 Feb; 31(2):433-438. PubMed ID: 27866700
[TBL] [Abstract][Full Text] [Related]
26. Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study.
Parise M; Tartaglione L; Cutruzzolà A; Maiorino MI; Esposito K; Pitocco D; Gnasso A; Irace C
J Med Internet Res; 2021 Apr; 23(4):e24552. PubMed ID: 33769945
[TBL] [Abstract][Full Text] [Related]
27. Association of serum C1q tumour necrosis factor-related protein 9 with the severity of lower extremity peripheral arterial disease in type 2 diabetes patients.
Jiang W; Tang Q; Zhang L; Chao Y; Hong B
Diab Vasc Dis Res; 2018 May; 15(3):270-273. PubMed ID: 29543038
[TBL] [Abstract][Full Text] [Related]
28. Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects.
Biscetti F; Bonadia N; Santini F; Angelini F; Nardella E; Pitocco D; Santoliquido A; Filipponi M; Landolfi R; Flex A
Cardiovasc Diabetol; 2019 Jan; 18(1):5. PubMed ID: 30634965
[TBL] [Abstract][Full Text] [Related]
29. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.
Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S
Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes.
Nativel M; Schneider F; Saulnier PJ; Gand E; Ragot S; Meilhac O; Rondeau P; Burillo E; Cournot M; Potier L; Velho G; Marre M; Roussel R; Rigalleau V; Mohammedi K; Hadjadj S
Diabetes Care; 2018 Oct; 41(10):2162-2169. PubMed ID: 30072406
[TBL] [Abstract][Full Text] [Related]
31. The Association Between Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes.
Kim MY; Kim G; Park JY; Choi MS; Jun JE; Lee YB; Jin SM; Hur KY; Kim JH
Diabetes Technol Ther; 2021 Jun; 23(6):434-442. PubMed ID: 33523771
[No Abstract] [Full Text] [Related]
32. Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes.
Guo QY; Lu B; Guo ZH; Feng ZQ; Yuan YY; Jin XG; Zang P; Gu P; Shao JQ
World J Diabetes; 2020 Nov; 11(11):489-500. PubMed ID: 33269061
[TBL] [Abstract][Full Text] [Related]
33. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
[TBL] [Abstract][Full Text] [Related]
34. Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy.
Yang J; Yang X; Zhao D; Wang X; Wei W; Yuan H
J Diabetes Investig; 2021 May; 12(5):828-836. PubMed ID: 32885597
[TBL] [Abstract][Full Text] [Related]
35. Ticagrelor and the Prevention of Microvascular Complications in Diabetes Patients with Lower Extremity Arterial Disease; Rationale and Design of the Hema-Kinesis Trial.
Rosenson RS; Chen Q; Najera SD; Lee ML; Cho DJ
Cardiovasc Drugs Ther; 2018 Oct; 32(5):443-451. PubMed ID: 30074112
[TBL] [Abstract][Full Text] [Related]
36. Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes.
Niu Y; Zhang W; Yang Z; Li X; Wen J; Wang S; Zhang H; Wang X; Zhou H; Fang W; Qin L; Su Q
BMC Cardiovasc Disord; 2015 Aug; 15():86. PubMed ID: 26260869
[TBL] [Abstract][Full Text] [Related]
37. Association between residual islet beta-cell function and achieving the target of time in range in inpatients with type 2 diabetes undergoing antidiabetic treatment: An observation study.
Xia Z; You W; Li Y; Li F; Hao S; Sun Y; Li N; Lin L; Dou J; Su X; Zhai Q; Zuo Y; Zhang Y; Gaisano HY; Zheng D; He Y; Jiang J
Diabetes Obes Metab; 2023 Jun; 25(6):1714-1722. PubMed ID: 36811214
[TBL] [Abstract][Full Text] [Related]
38. Ankle brachial index as a surrogate to vascular imaging in evaluation of peripheral artery disease in patients with type 2 diabetes.
Ugwu E; Anyanwu A; Olamoyegun M
BMC Cardiovasc Disord; 2021 Jan; 21(1):10. PubMed ID: 33407158
[TBL] [Abstract][Full Text] [Related]
39. Analysis of angiographic characteristics and intervention of vitamin D in type 2 diabetes mellitus complicated with lower extremity arterial disease.
Tan J; Lv H; Ma Y; Liu C; Li Q; Wang C
Diabetes Res Clin Pract; 2020 Nov; 169():108439. PubMed ID: 32926956
[TBL] [Abstract][Full Text] [Related]
40. Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial.
Rosenson RS; Chen Q; Najera SD; Krishnan P; Lee ML; Cho DJ
Cardiovasc Diabetol; 2019 Jun; 18(1):77. PubMed ID: 31174526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
